Medsource Ozone Biomedicals Profile
Key Indicators
- Authorised Capital ₹ 1.90 Cr
as on 17-12-2024
- Paid Up Capital ₹ 1.82 Cr
as on 17-12-2024
- Company Age 21 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.24 Cr
as on 17-12-2024
About Medsource Ozone Biomedicals
The Corporate was formerly known as Ozone Biomedicals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.90 Cr and a paid-up capital of Rs 1.82 Cr.
The company has closed loans amounting to ₹3.24 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shailesh Mittal, Prateek Mittal, and Devinjit Singh serve as directors at the Company.
- CIN/LLPIN
U85100DL2003PTC120213
- Company No.
120213
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2003
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Medsource Ozone Biomedicals Private Limited offer?
Medsource Ozone Biomedicals Private Limited offers a wide range of products and services, including Electrodiagnostic Instruments, Diagnostic Instruments, Corona Test Kit, RT PCR Test Kit, Pathology Lab Equipments, Elisa Reader, Hematology Analyzers, Hemoglobin Meter, Biochemistry Analyzer, Chemistry Analyzers.
Who are the key members and board of directors at Medsource Ozone Biomedicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Mittal  | Director | 04-Mar-2004 | Current |
| Prateek Mittal | Director | 02-Apr-2007 | Current |
| Devinjit Singh | Director | 02-Dec-2021 | Current |
Financial Performance of Medsource Ozone Biomedicals.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medsource Ozone Biomedicals?
Unlock access to Medsource Ozone Biomedicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹0
₹3.24 Cr
Charges Breakdown by Lending Institutions
- Vijaya Bank : 1.90 Cr
- Punjab National Bank : 1.25 Cr
- Viajay Bank : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2014 | Viajay Bank | ₹0.84 M | Satisfied |
| 31 Oct 2013 | Vijaya Bank | ₹4.00 M | Satisfied |
| 09 Mar 2012 | Vijaya Bank | ₹0.55 M | Satisfied |
| 05 Nov 2007 | Vijaya Bank | ₹9.50 M | Satisfied |
| 05 Nov 2007 | Vijaya Bank | ₹5.00 M | Satisfied |
How Many Employees Work at Medsource Ozone Biomedicals?
Unlock and access historical data on people associated with Medsource Ozone Biomedicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medsource Ozone Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medsource Ozone Biomedicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
